In the JournalsPerspective

GSK’s MMR vaccine safe, effective for US infants

March 22, 2019
GlaxoSmithKline’s measles, mumps and rubella vaccine was found to be safe and effective in healthy children in a phase 3 clinical trial. The…
FDA News

FDA committee OKs new H3N2 component for US flu vaccine

March 22, 2019
The FDA’s Vaccines and Related Biological Products Advisory Committee, or VRBPAC, voted unanimously today to approve a new H3N2 component for…
In the Journals

Updated guidance on asymptomatic bacteriuria adds patients who should not be tested

March 22, 2019
The Infectious Diseases Society of America has issued updated clinical practice guidelines for the management of asymptomatic bacteriuria, or ASB…
In the Journals

Bacteremia, meningitis rates twice as high among febrile neonates vs. infants

March 22, 2019
Although rates of bacterial meningitis are low among neonates and infants, researchers estimated that febrile children in the first month of life are…
Meeting News

Infective endocarditis related to IV drug use increasing hospital admissions, changing treatment paradigm

March 22, 2019
NEW ORLEANS — Hospital admissions for infective endocarditis related to IV drug use increased by 436% from 2012 to 2017 at Ohio State…

TB cases in US hit all-time low; declines insufficient to meet goals

March 22, 2019
Tuberculosis cases in the United States in 2018 fell to the lowest level ever reported, according to preliminary surveillance data, but the rate of…
Point/Counter

Would it be more beneficial to promote a pneumococcal vaccine that includes all or most serotypes to prevent disease or a ‘custom’ vaccine based on serotype prevalence?

Infectious Disease News, March 2019
Click here to read the Cover Story, “PCV13 vaccination highly effective but complicated by serotype replacement”. Point
Hooked on ID

with Dharushana Muthulingam, MD

Infectious Disease News, March 2019
“Typhus is not dead. It will live on for centuries and it will continue to break into the open whenever human stupidity and brutality give it a…
Feature

Phages: A promising alternative in the age of antibiotic resistance?

Infectious Disease News, March 2019
Steffanie Strathdee, PhD, thought they would “just ride it out.” The infectious disease epidemiologist believed her husband, Thomas
Cover Story

PCV13 vaccination highly effective but complicated by serotype replacement

Infectious Disease News, March 2019
Research has shown that bacteremic pneumococcal pneumonia may peak in late winter. According to the CDC, the populations at greatest risk for…
Pharmacology Consult

Montezuma’s revenge: A new treatment option

Infectious Disease News, March 2019
Jeff Brock, PharmD, MBA, BCPS-AQ ID
One of the most disappointing situations you can encounter while traveling is the dreaded travelers’ diarrhea. Travelers’ diarrhea is the…
Eye on ID

Acute flaccid myelitis: A mystery disease

Infectious Disease News, March 2019
Donald Kaye, MD, MACP
Acute flaccid myelitis, or AFM, is not a new syndrome or disease. The classical cause of the syndrome is infection with the poliomyelitis virus. Of…
In the Journals

Researchers sift through anti-vaccine Facebook comments to develop communication strategies

March 21, 2019
Researchers are now analyzing comments posted online by anti-vaccine advocates to help physicians tailor conversations with parents who are hesitant…
Perspective

Novel flu vaccine shows efficacy against mismatched H3N2 virus

March 21, 2019
Preliminary phase 2 data from a controlled human infection trial showed that an investigational influenza vaccine being developed by FluGen was…
In the Journals

Many patients with advanced cancer inappropriately treated for UTIs

March 20, 2019
Study findings showed that many patients with advanced cancer who are transitioning to comfort measures are inappropriately treated for UTIs, often…
In the Journals

CHG bathing not associated with lower risk for gram-negative infections

March 20, 2019
Results of a systematic review and meta-analysis showed that daily chlorhexidine bathing is not associated with a lower risk for gram-negative…
Meeting News

Pediatric nifurtimox formulations for Chagas disease show promise in phase 3 trial

March 20, 2019
A pediatric formulation of nifurtimox demonstrated superiority 1 year after treatment compared with placebo, according to results of a phase 3…

WHO launches global strategy against influenza

March 20, 2019
WHO recently announced a new global strategy for the years 2019 to 2030 that is aimed at protecting people in all countries from influenza. …
In the Journals

In anthrax attack, brief checklist can rapidly identify victims

March 19, 2019
A brief checklist detailing the signs and symptoms of anthrax illness can give medical personnel the ability to identify victims and “rapidly…

US on course to eliminate HCV among veterans within 2 months

March 19, 2019
The U.S. Department of Veterans Affairs announced that it is on track to eliminate hepatitis C in all veterans willing and able to receive treatment…